{
}
Dr. Marty Makary, nominated as FDA commissioner, faces scrutiny over his ties to the pharmaceutical industry, including a director position at Harrow and advisory roles with various health organizations. His connections may raise concerns during Senate confirmation hearings, especially as the FDA navigates issues surrounding GLP-1 medications. The history of FDA commissioners transitioning to industry roles adds to the debate on potential conflicts of interest in public health decisions.
The American Diabetes Association warns against the use of compounded versions of popular diabetes and weight loss drugs like Wegovy and Zepbound, citing concerns over safety, quality, and effectiveness. The organization urges healthcare professionals to adhere to approved formulations due to potential dosing errors and adverse events linked to compounded products. Amid ongoing shortages, the FDA has faced legal challenges regarding its enforcement of compounding regulations, complicating the landscape for these medications.
Scott Gottlieb
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Marty Makary's Industry Ties Raise Concerns Ahead of FDA Confirmation Hearings
United States Dollar
Novo Nordisk A/S
Nava Limited
Sesame
Sidecar Health
Eli Lilly and Company
Pfizer Inc.
Harrow, Inc.
USA
Scott Gottlieb
Lester Crawford
Marty Makary
Robert F. Kennedy Jr.
Donald Trump
Robert Califf
Show more
01:00 04.12.2024
Diabetes Group Warns Against Compounded Versions of Popular Weight Loss Drugs
01:00 02.12.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Finance Mergers & Acquisitions
Financial Scams and Security
Global Financial Events
Market Analysis and Predictions
Banking Regulations
Retail and Consumer Goods
Hedge Funds & Private Equity
Supply Chain Management
Global Trade Developments
Workplace Trends
Startups & Entrepreneurship
CEO Changes
AI Innovations
Real Estate Investments
Funding Rounds & Investments
Government Economic Policies
Cryptocurrency Trends
Countries:
Companies:
JPMorgan Chase & Co.
Barclays PLC
NVIDIA Corporation
Morgan Stanley
The Goldman Sachs Group, Inc.
Bank of America Corporation
Citigroup Inc.
Wells Fargo & Company
Tesla, Inc.
Apple Inc.
The Charles Schwab Corporation
Tesmec S.p.A.
Geode Capital Management LLC
State Street Corporation
Huawei Technologies CO. Ltd.
Netflix, Inc.
HSBC Holdings plc
Credit Suisse Real Estate Fund Siat
Charles Schwab Investment Management Inc.
Capital One Financial Corporation
Currencies:
United States Dollar
Chinese Yuan
Indian Rupee
British Pound Sterling
Swiss Franc
Euro
United Arab Emirates Dirham
South Korean Won
Canadian Dollar
Offshore Chinese Yuan
Japanese Yen
Azerbaijani Manat
New Taiwan Dollar
Saudi Riyal
Singapore Dollar
Vietnamese Đồng
Hong Kong Dollar
People: